Gary O'Donovan

Senior Scientist Ii, Target Enabling Technology-dna Encoded Library at AbbVie

Gary O'Donovan is a seasoned scientist specializing in DNA Encoded Library Technology (DEL) with extensive experience in the pharmaceutical industry. Currently serving as Senior Scientist II at AbbVie since March 2020, Gary previously held roles at DELscovery LLC, DICE Therapeutics, Nurix Therapeutics, GSK, and Praecis Pharmaceuticals, where contributions included the development and optimization of DEL platforms for lead generation across therapeutic targets. Gary's educational background includes a BSc in Chemistry of Pharmaceutical Compounds from University College Cork and participation in specialized programs focused on medicinal chemistry and drug discovery.

Links

Previous companies

Nurix logo

Timeline

  • Senior Scientist Ii, Target Enabling Technology-dna Encoded Library

    July, 2023 - present

  • Senior Scientist I, Augmented Molecular Design & Target Enabling Technology-dna Encoded Library

    March, 2020